Based on marketing researches, we analyze the marketing environment ofsafe meizitang

Based on marketing researches, we analyze the marketing environment ofsafe meizitang.  To reach the allow doctors to fully understand the purpose of the medicines, personal selling has become a way, which is the multinational pharmaceutical companies tend to have a team of thousands of people in pharmaceutical representative. (1), the two sides of the drugs any kind of there are side effects of drugs, to treat disease at the same time, said "As a saying in China, three-drug" The quality of the drugs also decided in efficacy to improve or remain unchanged under the premise of side effects will decrease, which became the pharmaceutical manufacturers in the development.
 Further market investigation show that the target consumers of safe meizitang are the office ladies. So the pricing of drugs is often reflects this characteristic, if a drug for the treatment of certain types of diseases is unique, pricing will be high for such drugs, the upper limit is generally the highest purchasing power of the pharmaceutical manufacturers hope people buy: the presence of a competitive product , the situation will change, because the efficacy of the price of competing products, to a certain extent, this time we must consider when pricing competition results, according to their own strengths and weaknesses of competitive products to select the right price.
As the rapid development of Chinese economic and great improvement in the standard of living, obesity is becoming a serious health problem. So ita engenders a great potential weight loss medication treatment market. For example, the Koran states that "safe meizitang helps him lose much weight.  As company in the wodd, Abbott Laboratoriesisa famous pharmaceutical want to launch Reductil in China, which weight loss drug that is firstly approved by FDA because ofthe assured curative effect. Like almost every industry in China, the weight loss medication treatment supplements in the market is market. highly competitive.
In Shanghai, Jiangsu, Zhejiang and other places the re-launch the product, whether to proceed with a national promotion and the sales situation, the original intention of this project. 1.3 the concept of obesity and its hazards of obesity is a chronic disease of the excessive accumulation of fat in a physical as well as a threat to health, the World Health Organization (WHO ) was officially announced that obesity is a disease of high prevalence of obesity in the United States, and rising over the past 10 years, the total incidence rate increased from 25% to 33%, an increase of 1/3 in 1999. It engenders a great potential safe meizitang treatment market. 
But in Asia there is a new problem, namely the problem of obesity in the level of a lower BMI than Westerners related diseases which may be deposited in the abdomen caused by the Asian fat, so the 2000 WHO specifically for the Asian developed a new obesity diagnostic criteria (Table 2). table an Asian adult BMI criteria and related disease risk classification weight is too low normal range, overweight in BMI (kg/m2) <18.5-related disease risk is low (but risk of other diseases increase) increase in average 18.5 ~~ 22.9 ≥ 23 with mild obesity, severe obesity 25 ~~ 29.9 ≥ 30 moderate increase significantly increase. Like almost every industry in China, safe meizitang is also having mass production.